17 completed, 1 terminated. 18 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 18 | Completed 17, Terminated 1 |
Follow Anaemia: new trials by email Literature Review of Anaemia trials Research Report on Anaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly Oral nutritional supplementation - Hypertension, Hand Grip Strength | Phase 1 | Completed | University of Ghana | 81 | 2025-11-24 | 2026-04-21 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Ferinject] - Iron Deficiency, Anaemia | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 84 | 2023-10-09 | 2024-04-18 |
| Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants Daprodustat - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 259 | 2020-12-18 | 2025-04-10 |
| Daprodustat Bioequivalence and Food Effect Study Daprodustat 2 mg tablet, Daprodustat 4 mg tablet - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 64 | 2018-04-24 | 2020-07-08 |
| Absorption and Elimination of Radiolabeled Daprodustat [14C]-GSK1278863 solution for IV infusion, [14C]-GSK1278863 oral solution, Daprodustat 6 mg oral tablet - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 6 | 2017-10-10 | 2019-12-03 |
| Daprodustat Hepatic Impairment Study Daprodustat (GSK1278863) - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 37 | 2017-07-24 | 2019-09-04 |
| Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers GSK1278863 25 mg Tablet, Pioglitazone 15 mg Tablet, Rosuvastatin 10 mg Tablet - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 70 | 2015-02-11 | 2017-11-17 |
| Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers GSK1278863 75 mg, GSK1278863 500 mg, Moxifloxacin 400 mg - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 61 | 2014-11-17 | 2018-07-24 |
| Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis GSK1278863 - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 8 | 2014-10-24 | 2019-04-09 |
| Multiple Ascending Dose Study of DS-1093 in Healthy Subjects DS-1093, placebo - Anaemia | Phase 1 | Completed | Daiichi Sankyo | 31 | 2014-05-01 | 2018-12-24 |
| Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers GSK1278863, Placebo - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 49 | 2012-05-15 | 2017-06-09 |
| Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment 5 mg GSK1278863 - Anaemia | Phase 1 | Terminated | GlaxoSmithKline | 22 | 2011-08-30 | 2019-06-28 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects GSK1278863A Placebo, GSK1278863A - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 34 | 2011-03-31 | 2017-06-22 |
| Relative Bioavailability Study for GSK1278863A GSK1278863A - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 30 | 2011-02-25 | 2017-06-26 |
| Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) GSK1278863, GSK1278863 + food, Gemfibrozil - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 23 | 2010-11-08 | 2017-06-09 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects GSK1278863A - Anaemia | Phase 1 | Completed | GlaxoSmithKline | 36 | 2008-07-07 | 2017-07-21 |
| Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects Epoetin Beta - Chronic Kidney Failure, Anaemia | Phase 1 | Completed | InCROM Europe Clinical Research | 23 | 2007-11-01 | 2010-03-12 |
| A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects GSK626616, placebo, midazolam, omeprazole, caffeine, flurbiprofen, rosiglitazone - Healthy Subjects, Anaemia | Phase 1 | Completed | GlaxoSmithKline | 90 | 2006-11-01 | 2012-03-19 |
Anemia (18) · Iron Deficiencies (2) · Body Weight (1) · Hypertension (1) · Kidney Failure, Chronic (1) · Protein Deficiency (1) · Renal Insufficiency, Chronic (1)
Hematologic Diseases (18) · Hemic and Lymphatic Diseases (18) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Iron Metabolism Disorders (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Renal Insufficiency (2) · Urogenital Diseases (2)
GSK1278863 (10) · Tablets (3) · Caffeine (1) · Dietary Supplements (1) · Flurbiprofen (1) · Food (1) · Gemfibrozil (1) · Infusions, Intravenous (1) · Midazolam (1) · Moxifloxacin (1) · Omeprazole (1) · Pioglitazone (1) · Rosiglitazone (1) · Rosuvastatin Calcium (1) · Trimethoprim (1)
GlaxoSmithKline (14) · Daiichi Sankyo (1) · InCROM Europe Clinical Research (1) · Sichuan Huiyu Pharmaceutical Co., Ltd (1) · University of Ghana (1)
United States (9) · Australia (2) · United Kingdom (2) · China (1) · Ghana (1) · India (1) · Japan (1)
Daryl Bendel, MBChB MBA (1) · Firibu K. Saalia, PhD in Food Science (1) · Gloria E. Otoo, PhD in Nutrition (1) · Jolene Nyako, PhD in Nutrition (1) · Li Xiang (1) · Matilda Steiner-Asiedu, PhD in Nutrition (1)
2014 (1), 2017 (1)